Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emergent BioSolutions

6.63
+0.58009.59%
Post-market: 6.640.0100+0.15%19:51 EDT
Volume:915.57K
Turnover:5.92M
Market Cap:359.86M
PE:-2.70
High:6.67
Open:6.17
Low:6.16
Close:6.05
Loading ...
Jun 07, 2022

Major Issues Report

8-K - Current report
Jun 06, 2022

Major Issues Report

8-K - Current report
May 27, 2022

Major Issues Report

8-K - Current report
May 18, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Major Issues Report

8-K - Current report
Apr 29, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 28, 2022

Major Issues Report

8-K - Current report
Mar 23, 2022

Major Issues Report

8-K - Current report
Mar 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 25, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 24, 2022

Major Issues Report

8-K - Current report
Feb 22, 2022

Major Issues Report

8-K - Current report
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 14, 2022

Major Issues Report

8-K - Current report
Jan 10, 2022

Major Issues Report

8-K - Current report
Dec 09, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 07, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 15, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 12, 2021

Correspondence

CORRESP [Cover] - Correspondence